H Mouriesse
Overview
Explore the profile of H Mouriesse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
428
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Petit J, Le M, Rietjens M, Contesso G, Lehmann A, Mouriesse H
Tumori
. 1998 Dec;
84(5):525-8.
PMID: 9862510
Background: An increased risk of cancer and autoimmune diseases associated with gel-filled silicone implants, debated by FDA experts since 1991, has given rise to a profusion of literature on the...
2.
Le Vu B, Dumortier A, Guillaume M, Mouriesse H, Barreau-Pouhaer L
Bull Cancer
. 1998 Jan;
84(10):957-61.
PMID: 9435797
We have compared different modes of rehabilitation after breast cancer surgery on a population of 257 patients treated at the Institute Gustave-Roussy in 1990 and 1991. The mode of rehabilitation...
3.
Petit J, Rietjens M, Le M, Mouriesse H
Ann Chir Plast Esthet
. 1997 Apr;
42(2):107-9.
PMID: 9768144
The authors discuss the immunological and oncological risk of prefilled silicone gel breast implants. A comparative study of 146 patients undergoing breast reconstruction by silicone implant at the Institut Gustave-Roussy...
4.
Terrier P, Mouriesse H, Loridon B, Gotteland M, DELARUE J
Acta Oncol
. 1996 Jan;
35(1):23-30.
PMID: 8619936
A rabbit-specific polyclonal antibody was obtained raised to a synthetic peptide corresponding to the 1238-1255 C-terminal predicted sequence of the c-erbB-2 protein. This antibody was used in an immunohistochemical procedure...
5.
Thomas F, Arriagada R, Spielmann M, Mouriesse H, Le Chevalier T, Fontaine F, et al.
Cancer
. 1995 Dec;
76(11):2286-90.
PMID: 8635033
Background: Patients with inflammatory breast cancer have a high risk of developing a local recurrence and/or distant metastases. Treatment with combined chemotherapy and locoregional radiotherapy contributes to a decrease in...
6.
Sancho-Garnier H, DELARUE J, Mouriesse H, Contesso G, Gotteland M, May E
Eur J Cancer
. 1995 Oct;
31A(11):1851-5.
PMID: 8541112
Recently, it was found that, among post menopausal breast cancer patients receiving no adjuvant therapy, the highest oestrogen receptor (ER) levels (ER++) as opposed to the intermediate ER levels (ER+)...
7.
Contesso G, Mouriesse H
Arch Anat Cytol Pathol
. 1995 Jan;
43(1-2):44-50.
PMID: 7794026
Identified half a century ago as a favorable prognostic form, medullary breast cancer was classified by Ridolfi in 1977 as necessarily combining 5 features: seemingly wall-circumscribed histological limits, a syncytial...
8.
Petit J, Rietjens M, Le M, Mouriesse H
Ann Chir Plast Esthet
. 1994 Dec;
38(6):801-3.
PMID: 7847730
No abstract available.
9.
DELARUE J, Terrier P, Terrier-Lacombe M, Mouriesse H, Gotteland M
Bull Cancer
. 1994 Dec;
81(12):1067-77.
PMID: 7742595
In order to determine the prognostic value of c-erbB-2 protein and Epidermal Growth Factor Receptor (EGF-R), we used an immunohistochemical procedure with specific antibodies on paraffin-embedded material from a series...
10.
Gotteland M, May E, Contesso G, DELARUE J, Mouriesse H
Cancer
. 1994 Aug;
74(3):864-71.
PMID: 7913659
Background: The response to endocrine therapy is not entirely predictable from the estrogen receptor (ER) and progesterone receptor (PgR) status of primary breast tumors. The authors previously proposed a new...